Tuesday, March 17, 2026

THE NEXT CALIBER : Why Kim Jong Un Is Handing The Weapon To His Successor Now

Kim Jong Un inspected a munitions factory, emphasizing modernization and new production lines for enhancing military capabilities.

Samsung Unveils AI-Driven HVAC Innovations at AHR Expo 2026: Discover the Future of Energy Efficiency

Samsung Electronics showcases HVAC products and AI solutions at AHR Expo, targeting North American market with innovative technologies.

Will Coupang Face U.S. Trade Law 301? What You Need to Know About This Potential Impact on Korean Business

Coupang faces potential U.S. trade investigation over FTA violations, testing South Korea's trade diplomacy amid investor claims of discrimination.

Tag: CDMO

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Samsung Biologics: How a 56 Billion USD CDMO Leader is Shaping the Future of Biopharmaceuticals

Samsung Biologics is evolving as a leading CDMO, targeting a production capacity of 1.32M liters by 2030 after its spin-off from Bioepis.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

GAME OVER: Samsung Biologics Declares War With ‘ExellenS’—A Standard That Kills All Biotech Competition

Samsung Biologics launches ExellenS in Europe, enhancing biopharmaceutical production with standardized quality and efficiency.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.